According to Roche's latest financial reports the company's current EPS (TTM) is $22.05. In 2022 the company made an earnings per share (EPS) of $22.05 a decrease over its 2021 EPS that were of $23.52.
Year | EPS | Change |
---|---|---|
2022 | $22.05 | -6.29% |
2021 | $23.52 | -5.53% |
2020 | $24.90 | 16.56% |
2019 | $21.36 | 30.3% |
2018 | $16.40 | 20.22% |
2017 | $13.64 | -5.81% |
2016 | $14.48 | 4.62% |
2015 | $13.84 | -5.13% |
2014 | $14.59 | -25.05% |
2013 | $19.46 | 21.73% |
2012 | $15.99 | 3.82% |
2011 | $15.40 | 8.16% |
2010 | $14.24 | 23.72% |
2009 | $11.51 | -12.31% |
2008 | $13.12 | -0.34% |
2007 | $13.17 | 32.13% |
2006 | $9.97 | 42.56% |
2005 | $6.99 | -22.7% |
2004 | $9.04 | 132.85% |
2003 | $3.88 | -154.73% |
2002 | -$7.10 | -209.09% |
2001 | $6.50 | -57.25% |
2000 | $15.21 | 54.06% |
1999 | $9.88 | 31.24% |
1998 | $7.52 |